Chronic pancreatitis: Diagnosis, classification, and new genetic developments

Gastroenterology

Volumn 120, Issue 3, 2001, Pages 682-707

  Etemad, Babak ^a   Whitcomb, David C ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC PANCREATITIS; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035109764     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22586     Document Type: Article

References (242)

1. The natural history of hereditary chronic pancreatitis: A study of 12 cases compared to chronic alcoholic pancreatitis
2. The natural history of pain in alcoholic chronic pancreatitis
3. AGA technical review: Treatment of pain in chronic pancreatitis
4. Risk factors for cancer in hereditary pancreatitis
5. Pancreatitis and the risk of pancreatic cancer
6. Hereditary pancreatitis and the risk of pancreatic cancer
7. Pancreatitis and pancreatic cancer: A population-based study
8. Pancreatitis is a risk factor for pancreatic cancer
9. Pancreatitis and the risk of pancreatic cancer
10. Course of alcoholic chronic pancreatitis: A prospective clinicomorphological long-term study
11. Pathology of acute and chronic pancreatitis
12. A morphological analysis of 57 resection specimens and 9 autopsy pancreata
13. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society
14. Chronic pancreatitis
15. Chronic pancreatitis
16. Chronic pancreatitis
17. Diagnosis of chronic pancreatitis: Is a gold standard necessary?
18. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
19. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
20. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis
21. SPlNK1/PSTl polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis
22. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
23. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
24. Hereditary pancreatitis: New insights into acute and chronic pancreatitis
25. Genetic predispositions to acute and chronic pancreatitis
26. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer
27. Surgical managemerit of chronic pain from chronic pancreatitis
28. Pain management in chronic pancreatitis
29. Pancreatitis definitions and classification
30. A new classification system for acute pancreatitis
31. Proposal adopted unanimously by the participants of the Symposium, Marseilles 1963
32. Revised classification of pancreatitis: Report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28-30, 1984
33. The pancreatitis classification of Marseilles, Rome 1988
34. Definitions of acute and chronic pancreatitis
35. Classification of pancreatitis
36. Progression from acute to chronic pancreatitis: A physician's view
37. A clinically based classification system for alcoholic chronic pancreatitis: Summary of an international workshop on chronic pancreatitis
38. The problem of classification and staging of chronic pancreatitis: Proposal based on current knowledge and its natural history
39. A plea for uniform reporting of patient outcome in chronic pancreatitis
40. Copenhagen pancreatitis study. An interim report from a prospective epidemiological multicentre study
41. Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988
42. Chronic pancreatitis in Mexico City
43. Incidence of alcoholic chronic pancreatitis in Copenhagen
44. Self-reported alcohol consumption among adolescents and the signification of early onset. A longitudinal approach
45. Alcohol consumption and divorce rates in the United States
46. Nationwide epidemiological survey of chronic pancreatitis in Japan
47. Progression of alcoholic acute to chronic pancreatitis
48. Minimal change chronic pancreatitis
49. Correlation of imaging and function in chronic pancreatitis
50. Computed tomography of the pancreas
51. CT- and US-guided biopsy of the pancreas
52. CT-guided biopsy: Prospective analysis of 1,000 procedures
53. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography
54. Non-alcoholic duct destructive chronic pancreatitis
55. Endoscopic ultrasonography in chronic pancreatitis: A comparative prospective study with conventional ultrasonography, computed tomography and ERCP
56. Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis
57. CT demonstration of fibrous stroma in chronic pancreatitis: Pathologic correlation
58. Pancreatic ductal adenocarcinoma: Diagnosis and staging with dynamic CT
59. Quantitative evaluation of pancreatic enhancement during dual-phase helical CT
60. A comparison of two injection protocols using helical and dynamic acquisitions in CT examinations of the pancreas
61. Pancreatic adenocarcinoma: Designing the examination to evaluate the clinical questions
62. Autoimmune pancreatitis: Radiologic findings in three histologically proven cases
63. Sensitivity of endoscopic retrograde pancreatography in chronic pancreatitis
64. Pancreatic lithiasis in the aged. Its clinicopathology and pathogenesis
65. Endoscopic pancreatocholangiography. II. The pathological endoscopic pancreatocholangiogram
66. Recurrent acute pancreatitis: An algorithmic approach to identification and elimination of inciting factors
67. Endoscopic ultrasonography of chronic pancreatitis and pancreatic pseudocysts
68. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin
69. How much experience is required to correctly interpret EUS features of chronic pancreatitis? A multicenter prospective trial of 3rd tier EUS trainees compared to a consensus of experts
70. 3D-endosonography in gastroenterology: Methodology and clinical applications
71. Molecular imaging: Exploring the next frontier
72. How many supervised procedures does it take to become competent in EUS? - Results of a multicenter study
73. Magnetic resonance pancreatography (MRP)
74. Severe chronic pancreatitis versus suspected pancreatic disease: Dynamic MR cholangiopancreatography after secretin stimulation
75. Chronic pancreatitis: Evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation
76. Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma
77. Pancreatic carcinoma versus chronic pancreatitis: Dynamic MR imaging
78. Comparison of endoscopic retrograde cholangiopancreatography with MR cholangiopancreatography in patients with pancreatitis
79. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency
80. Relationship between pancreatic exocrine function and ductal morphology in chronic pancreatitis
81. Novel approaches to the diagnosis of pancreatic disease in childhood
82. Pancreatic enzymes: Secretion and luminal nutrient digestion in health and disease
83. Diagnosis of chronic pancreatitis
84. Update on diagnosis and management of chronic pancreatitis
85. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
86. New concepts in understanding the pathophysiology of chronic pancreatitis
87. Acute pancreatitis is not a cause of chronic pancreatitis in the absence of residual duct strictures
88. Chronic pancreatitis and diabetes
89. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine
90. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
91. Lithostathine messenger RNA expression in different types of chronic pancreatitis
92. Early trypsinogen activation in acute pancreatitis
93. Pancreatic stellate cells: The new stars of chronic pancreatitis?
94. Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture
95. Identification, culture, and characterization of pancreatic stellate cells in rats and humans
96. Chronic relapsing pancreatitis
97. Chronic pancreatitis
98. Etiology of chronic calcifying pancreatitis in Brazil: A report of 329 consecutive cases
99. Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreatitis and alcohol, protein and lipid consumption
100. Cirrhosis and chronic pancreatitis in alcoholics
101. Alcoholic pancreatitis: Unraveling the mystery
102. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
103. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: A meta-analysis
104. Effect of chronic ethanol feeding on digestive enzyme synthesis and mRNA content in rat pancreas
105. A review: Acute and chronic effects of ethanol and alcoholic beverages on the pancreatic exocrine secretion in vivo and in vitro
106. Individual susceptibility to alcoholic pancreatitis: Still an enigma
107. Racial factors and the risk of chronic pancreatitis
108. Role of alcohol dehydrogenase polymorphism in ethanol metabolism and alcohol-related diseases
109. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage
110. HLA antigens in chronic alcoholic pancreatitis
111. HLA antigens in chronic pancreatitis
112. HLA-B13 and chronic calcific pancreatitis
113. HLA antigen and chronic pancreatitis in Japan
114. Evidence for an inherited predisposition to alcoholic pancreatitis. A controlled HLA typing study
115. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis
116. Screening for mutations of the cationic trypsinogen gene: Are they of relevance in chronic alcoholic pancreatitis?
117. Inherited susceptibility to alcohol-induced acute pancreatitis
118. Alcoholic pancreatitis: From what histological starting point?
119. Does acute alcoholic pancreatitis exist without preexisting chronic pancreatitis?
120. Death due to acute pancreatitis: A retrospective analysis of 405 autopsy cases
121. Development of chronic pancreatitis (CP) in humans after the first attack of acute pancreatitis (AP) is associated with the severity of the first attack of AP
122. Smoking and alcoholic pancreatitis
123. Cigarette smoking: An independent risk factor in alcoholic pancreatitis
124. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer
125. Cigarette smoking as a risk factor for chronic pancreatitis: A case-control study in Japan
126. Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis?
127. Pancreatitis in a native American Indian population
128. Inhibition of pancreatic secretion in man by cigarette smoking
129. Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration
130. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat
131. Proteolysis of human trypsinogen. I. Pathogenic implications in chronic pancreatitis
132. The two human trypsinogens: Catalytic properties of the corresponding trypsins
133. Pancreatitis, a diagnostic clue to hyperparathyroidism
134. Hereditary hyperparathyroidism associated with recurrent pancreatitis
135. Hyperparathyroidism and pancreatitis. Chance or a causal association?
136. Hyperparathyroidism associated with chronic pancreatitis in a family
137. The association of primary hyperparathyroidism and pancreatitis
138. Chronic pancreatitis
139. Chronic and relapsing acute pancreatitis associated with chronic renal insufficiency and analgesic (phenacetin) abuse. Observations in 4 patients
140. Sonographic changes of the pancreas in chronic renal failure
141. The influence of ethanol on long-term effects of dibutyltin dichloride (DBTC) in pancreas and liver of rats
142. Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): Pathogenesis and natural course of lesions
143. The course of pancreatic fibrosis induced by dibutyltin dichloride (DBTC)
144. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride
145. Gastrointestinal complications of renal failure
146. Acute pancreatitis in chronic renal failure
147. Acute pancreatitis in patients with end-stage renal disease without transplantation
148. Histological pancreatitis in end-stage renal disease
149. High prevalence of pancreatic disease in chronic renal failure
150. Origin and development of exocrine pancreatic insufficiency in experimental renal failure
151. Pancreatic exocrine function in severe human chronic renal failure
152. Gastric and pancreatic function in patients with end-stage renal disease
153. Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh
154. Pedigree of a family with hereditary chronic relapsing pancreatitis
155. CFTR mutations predispose to chronic pancreatitis without cystic fibrosis lung disease
156. Pancreatic secretory enzymes
157. Trypsinogen mutations in chronic pancreatitis
158. Recommendations for a nomenclature system for human gene mutations
159. Two mutations in rat trypsin confer resistance against autolysis
160. Hereditary pancreatitis-associated mutation asn(21)→ile stabilizes rat trypsinogen in vitro
161. A new polymorphism for the R117H mutation in hereditary pancreatitis
162. Hereditary pancreatitis and familial pancreatic cancer
163. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis
164. Evidence for further mutations of the cationic trypsinogen in hereditary pancreatitis
165. Mutations in exon 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis
166. Screening for a point mutation of cationic trypsinogen in patients with pancreatic disease
167. Molecular pathogenesis of chronic pancreatitis associated with abnormal CFTR genotypes
168. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis
169. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis
170. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation
171. Genetic testing: Counseling, laboratory and regulatory issues and the EUROPAC protocol for ethical research in multi-center studies of inherited pancreatic diseases
172. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis
173. The First International Symposium on Hereditary Pancreatitis
174. Hereditary pancreatitis: Clinical characteristics of a large kindred
175. Hereditary pancreatitis in England and Wales
176. Hereditary pancreatitis
177. Hereditary pancreatitis: New insights, new directions
178. Clinical characteristics of hereditary pancreatitis in a large family based on high-risk haplotype
179. Protection of human subjects; reports of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research - Office of the Assistant Secretary for Health, HHS. Notice of availability of reports
180. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
181. The genetic testing of children - Working party of the clinical genetics society
182. A prospective study of cigarette smoking and the risk of pancreatic cancer
183. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers
184. Preventative strategies and therapeutic options for hereditary pancreatitis
185. Hereditary pancreatitis and pancreatic carcinoma
186. Pancreatic cancer surveillance in a high-risk cohort: Is it worth the cost?
187. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
188. Pancreatitis and mutations of the cystic fibrosis gene
189. Genotype and phenotype in cystic fibrosis
190. Cystic fibrosis: Genotypic and phenotypic variations
191. Pancreatic aspects of cystic fibrosis and other inherited causes of pancreatic dysfunction
192. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
193. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance
194. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens
195. High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia
196. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis
197. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion
198. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis
199. Alpha-1-antitrypsin and chronic pancreatitis
200. Chronic pancreatitis and alpha-1-antitrypsin
201. Alpha 1 antitrypsin phenotypes and alcoholic pancreatitis
202. Observations on 205 confirmed cases of acute pancreatitis, recurrent pancreatitis, and chronic pancreatitis
203. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis
204. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas
205. Primary sclerosing cholangitis in Japan - Analysis of 192 cases
206. Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis
207. Chronic pancreatitis and inflammatory bowel disease: True or coincidental association?
208. Autoimmune pancreatitis: CT and MR characteristics
209. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy
210. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response
211. Does acute pancreatitis progress to chronic pancreatitis? A microvascular pancreatitis model in the rat
212. Recovery of the pancreas after acute pancreatitis is not necessarily complete
213. Clinical assessment of hypedipidemic pancreatitis
214. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes
215. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II
216. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis
217. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: Clinical and biochemical features and Hphl restriction enzyme polymorphism
218. Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred
219. Hyperlipidemic pancreatitis
220. Etiopathogenesis and definition of chronic pancreatitis
221. Chronic obstructive pancreatitis as a delayed complication of pancreatic trauma
222. Obstructive pancreatitis: Unusual causes of chronic pancreatitis
223. Chronic obstructive pancreatitis, nesidioblastosis, and small endocrine pancreatic tumor
224. Sphincter of Oddi dysfunction is associated with chronic pancreatitis
225. Sphincter of Oddi dysfunction
226. Hereditary chronic relapsing pancreatitis. A clue to pancreatitis in general?
227. Invasive pancreatic function testing: A survey of methods and numbers of procedures performed in the United States
228. Function tests in the diagnosis of chronic pancreatitis. Critical evaluation
229. Pancreatic secretion
230. Chronische pankreatitis. Update: Diagnostik und Therapie 2000
231. The pancreolauryl test. A method of assessing the combined functional efficacy of pancreatic esterase and bile salts in vivo?
232. Pancreolauryl test for pancreatic exocrine insufficiency
233. Optimized serum pancreolauryl test for differentiating patients with and without chronic pancreatitis
234. Fate of pancreatic enzymes during small intestinal aboral transit in humans
235. Faecal elastase 1: A novel, highly sensitive, and specific tubeless pancreatic function test
236. Fecal elastase test: Evaluation of a new noninvasive pancreatic function test
237. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis
238. Fecal elastase 1 determination in chronic pancreatitis